Junyong Weng
Overview
Explore the profile of Junyong Weng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
500
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Yang Y, Luo D, Shao Y, Shan Z, Liu Q, Weng J, et al.
Cancer Commun (Lond)
. 2022 Nov;
43(1):100-122.
PMID: 36328987
Background: Circular RNAs (circRNAs) generated by back-splicing of precursor mRNAs (pre-mRNAs) are often aberrantly expressed in cancer cells. Accumulating evidence has revealed that circRNAs play a critical role in the...
12.
Hao J, Mei H, Luo Q, Weng J, Lu J, Liu M, et al.
Carcinogenesis
. 2022 Nov;
44(1):29-37.
PMID: 36317339
Gastric cancer is the third most commonly cause of tumour-related death worldwide and one of the most prevalent malignancies in China. TCL1A, TCL1 family Akt coactivator A, can active Akt/mTOR...
13.
Zhu Z, Zhao Q, Song W, Weng J, Li S, Guo T, et al.
Front Immunol
. 2022 Oct;
13:940774.
PMID: 36248908
Cuproptosis, or copper-induced cell death, has been reported as a novel noncanonical form of cell death in recent times. However, the potential roles of cuproptosis in the alteration of tumor...
14.
Weng J, Li S, Zhu Z, Liu Q, Zhang R, Yang Y, et al.
J Hematol Oncol
. 2022 Jul;
15(1):95.
PMID: 35842707
Chemotherapy combined with or without targeted therapy is the fundamental treatment for metastatic colorectal cancer (mCRC). Due to the adverse effects of chemotherapeutic drugs and the biological characteristics of the...
15.
Lin H, Weng J, Mei H, Zhuang M, Xiao X, Du F, et al.
J Gastroenterol Hepatol
. 2020 Jul;
36(2):455-466.
PMID: 32667711
Background And Aim: 5-Lipoxygenase has been reported to enhance cell proliferation, migration, and invasion. Epithelial-mesenchymal transition is considered an important process for tumor metastasis and invasion. Methods: The 5-lipoxygenase expression...
16.
Li S, Li L, Wu J, Song F, Qin Z, Hou L, et al.
Onco Targets Ther
. 2020 Jul;
13:5845-5855.
PMID: 32606795
Purpose: Tryptophan 2,3-dioxygenase (TDO), encoded by the gene TDO2, is an enzyme that catalyses the first and rate-limiting step of tryptophan (Try) degradation in the kynurenine (Kyn) pathway in the...
17.
Li S, Weng J, Song F, Li L, Xiao C, Yang W, et al.
Cell Death Dis
. 2020 Jun;
11(6):452.
PMID: 32532962
As a recently discovered noncoding RNA, circular RNAs (circRNAs) have been identified to play key roles in cancer biology; however, the detailed functions and mechanisms of circRNAs in hepatocellular carcinoma...
18.
Weng J, Li S, Lin H, Mei H, Liu Y, Xiao C, et al.
Cell Death Dis
. 2020 Apr;
11(3):206.
PMID: 32231199
Gastric cancer (GC) has a high mortality rate, and metastasis is the main reason for treatment failure. It is important to study the mechanism of tumour invasion and metastasis based...
19.
Ding X, Huang R, Zhong Y, Cui N, Wang Y, Weng J, et al.
Biomed Pharmacother
. 2019 Dec;
123:109742.
PMID: 31855733
Metastasis is the main cause of gastric cancer (GC) related death and the underlying mechanisms still remain unclear. Collagen triple helix repeat containing 1 (CTHRC1) protein is known to be...
20.
Xiao C, Wu G, Zhou Z, Zhang X, Wang Y, Song G, et al.
Cell Death Dis
. 2019 Nov;
10(11):833.
PMID: 31685801
RBBP6 has been implicated in tumorigenesis but its role in tumor metastasis and progression has not been evaluated. Interestingly, here we show that RBBP6 is upregulated in colorectal cancer (CRC)...